NDC product
Zinc Cold Therapy
NDC 63868-287 · Chain Drug Manufacturing Assn
Key facts
| Product NDC | 63868-287 |
|---|---|
| Proprietary name | Zinc Cold Therapy |
| Nonproprietary name | ZINC GLUCONATE |
| Substances | ZINC GLUCONATE |
| Dosage form | TABLET |
| Route | ORAL |
| Labeler | Chain Drug Manufacturing Assn |
| Product type | HUMAN OTC DRUG |
| Marketing category | UNAPPROVED HOMEOPATHIC |
| Pharmacologic classes | Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE] |
| Marketing start | May 1, 2018 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: